A drug used to treat MS may work on additional diseases. Cramer talked with the CEO.
The company is Acorda Therapeutics, (TICKER: ACOR), a small, billion dollar biopharma firm that's focused on neurology.
Back in 2010, Acorda received FDA approval for a drug called Ampyra that helps people with multiple sclerosis regain some of their ability to walk.
Cramer talked about other companies behind treatments for MS earlier in the week. Click here to go to "Don't Overlook This Biotech"